Cancer drug lessens the toxicity of a protein from COVID-19 virus

(University of Maryland School of Medicine) University of Maryland School of Medicine (UMSOM) researchers have identified the most toxic proteins made by SARS-COV-2--the virus that causes COVID-19 - and then used an FDA-approved cancer drug to blunt the viral protein's detrimental effects.